Summary.-Animals treated with a sufficiently high dose of busulphan die about 14 days later from bone marrow failure. A single, appropriately timed injection of cyclophosphamide can save these mice. The nature of this protection is shown to be the cyclophosphamide induced elaboration of a humoral factor which stimulates haemopoietic recovery.
THE USE of cytotoxic agents in cancer chemotherapy is often limited by the action of these agents on the normal, homoeostatic, proliferating cells of the body, particularly those of the bone marrow. Any substance which enhances haemopoietic recovery, particularly during bone marrow depression induced by cytotoxic agents, is of importance.
Cyclophosphamide, in addition to having a cytotoxic effect on the proliferating haemopoietic cells of the bone marrow, appears also to enhance subsequent recovery of these cells (Gregory et al., 1971; Fried et al., 1973) . Evidence that a long-range diffusible substance is involved in this stimulation was presented by Stohlman et al. (1973) . These authors observed enhanced growth of bone marrow in diffusion chambers implanted in cyclophosphamide treated hosts.
The timing of the administration of cyclophosphamide is important in relation to the transplantation of the bone marrow (Gregory et al., 1971; Fried et al., 1973 ) the cyclophosphamide being given between 1 and 4 days before the transplantation for optimum stimulation. Gregory et al. (1971) have suggested that the cyclophosphamide may cause the elaboration of a substance as a result of cell damage which stimulates haemopoietic stem cell recovery. Dons et al. (1974) Serum-.Mice were given 200 mg/kg cyclophosphamide and 2 days later bled from the axilla. The blood was allowed to clot overnight at 4°C. After centrifugation the serum was removed, passed through a 0 22 jtm Millipore filter and dialysed in 8/32
Visking tubing against distilled water for 3 days at 4°C. The water, which contained 250,000 u of both penicillin and streptomycin per litre, was changed twice during the dialysis. The product was centrifuged to remove the precipitate, which was resuspended in isotonic saline to its original concentration. Test sera were injected intraperitoneally in 0 * 5 ml aliquots daily for three days following the busulphan.
RESULTS
Effect of the combination of cyclophosphamide and busulphan on the primary animal Animal sarvival.-Cyclophosphamide (200 mg/kg) was given to animals lethally treated with busulphan (35 mg/kg or 45 mg/kg) at different times before or after the busulphan (Table la) . These doses of busulphan result in the death of at least 90%/ of the treated animals in 30 days but the dose of cyclophosphamide used has never produced any deaths over the 30-day period investigated. The survival of animals that received the lethal dose of busulphan as well as the cyclophosphamide improved dramatically when the cyclophosphamide was injected one or 2 days before the busulphan. At other times the survival was less, but generally better than that of animais receiving no cyclophosphamide. Table lb indicates that the spleen does not play a major role in this effect. Using the optimum timing and order of administration of the drugs, it was shown that the considerable sparing effect seen in Table la could be obtained in animals recently splenectomized or splenectomized for some time compared with similar animals receiving busulphan alone.
Effect on blood granulocyte concezitration. The effect of cyclophosphamide (200 mg/kg), busulphan (30 mg/kg) and a combination of the two drugs on the time course of blood granulocyte concentration is shown in the Figure. The combination, cyclophosphamide given 48 h before busulphan, is that which gives the best survival as judged by Table la. A reduced dose of busulphan (30 mg/ kg) was used to allow 21-day survival in groups of animals given busulphan alone. An animal receiving this drug alone initially maintains a high blood granulocyte concentration ( Figure) ; the granulocyte concentration then falls, there is an abortive recovery Day 7 to 9 and finally it reaches its lowest value after 14 The experiments, performed in both normal and splenectomized animals various days after treatment with busulphan and serum, show that the serum had no stimulating effect on CFU recovery, whether it came from normal animals or from animals given cyclophosphamide. Indeed, in many instances animals given no serum at all have higher CFU levels per femur than those given serum.
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DISCUSSION
The improved survival of mice treated with busulphan and cyclophosphamide is greatest when the cyclophosphamide is Percentage of Control given 1-2 days before the busulphan. However, there is still improved survival when cyclophosphamide is given after the busulphan, indicating that the improved survival is not simply a result of the cyclophosphamide interfering with the action of busulphan.
Cyclophosphamide has been shown to enhance the regeneration of transplanted CFU (Fried and Johnson, 1968; Gregory et al., 1971) although the mechanism of this effect remains unclear. Fried et al. (1973) failed to demonstrate the presence of a humoral factor in plasma from animals treated with cyclophosphamide which could stinmulate CFU regeneration in irradiated animals. They concluded that cyclophosphamide may have its effect at a local level by destroying many of the bone marrow cells and thus removing cell-cell contact inhibition.
We, too, have failed to demonstrate a serum factor capable of restoring CFU number even though the serum does contain a factor which will increase blood granulocyte concentration and improve survival of lethally treated mice. However, other workers have reported that the recovery of stem cells (CFU) has been influenced by the administration of various substances. An alpha macroglobulin prepared from mouse, or rat serum (Nettesheim, Hanna and Fisher, 1968 ) and cell-free spleen extracts are reported to enhance CFU regeneration in mice given 200 rad (Knospe et al., 1970) .
Most recently, fetuin, an alpha macroglobulin extracted from foetal calf serum, has been shown to enhance CFU regeneration in sub-lethally irradiated mice (Dons et al., 1974) .
It seems likely therefore that humoral stimulators of granulopoiesis exist which restore granulopoiesis after damage by irradiation or cytotoxic drugs and that this is not confined to restoration of the stem cell pool but also enhancement of differentiation along the granulocytic pathway. An animal's survival does not depend on stem cells alone but on the capacity of these cells to form functional progeny and the degree of stimulus to do so. This is borne out by the disparity between CFU content of the femur and actual survival of the animal after various cytotoxic treatments seen by other workers (Hanks and Ainsworth, 1964; Smith et al., 1966; Yuhas and Storer, 1969; Dunn and Elson, 1970; Dunjic and Cuvelier, 1973) , and this emphasizes the limitation of predicting haemopoietic recovery in terms of CFU measurement only.
An important question arises as to the relationship between the factor reported here and CSF, the factor necessary for the in vitro growth of granulocvtic and monocytic colonies. It has been shown that there is a rapid increase in CSF in the serum of animals treated with bacterial endotoxin (Quesenberry et al., 1972) . In our system the action of cyclophosphamide on the cells of the intestinal epithelium may have led to a cellular breakdown and bacterial invasion from the gut flora. The subsequent bacteriaemia could have led to high levels of CSF at the time when serum was collected for analysis.
The presence of high levels of CSF in the serum 2 days after cyclophosphamide is unlikely, however, as it has not been detected under these conditions by Shadduck and Nagabhushanam (1971) or by us (unpublished observations) using the in vitro colony forming assay (Pluznik and Sachs, 1965; Bradley and Metcalf, 1966) . Nevertheless, work is in progress to assess the effects of bacterial endotoxin and endotoxin treated mouse serum in sparing animals from busuilphan induced bone marrow failure. The work started by Smith, Alderman and Gillespie (1957) and Hanks and Ainsworth (1964) has made this an important consideration.
